Vendor Information:

ETOP IBCSG Partners Foundation was established in 1977 as the Ludwig Breast Cancer Study Group and has evolved through mergers, notably with the European Thoracic Oncology Platform (ETOP) in 2021. It operates as a Swiss foundation governed by the ETOP IBCSG Partners Foundation Board. The headquarters is located in Bern, Switzerland, with additional centers in Boston, USA, Amherst, USA, and Milan, Italy. The foundation specializes in breast cancer research and operates globally, involving participants from six continents. The mission of the foundation is to improve the prognosis and quality of life for women with breast cancer through innovative clinical research.

Specialization and Scope of Services:

The ETOP IBCSG Partners Foundation specializes in breast cancer research. The main areas of operation include:

Clinical Trials
Translational Research
Biobank Management
Scientific Publications
Research Collaboration

Specific services offered include conducting clinical trials, managing a biobank of breast cancer specimens, publishing research findings, and collaborating on international research projects.

Experience and Qualifications:

The foundation has over 40 years of experience in breast cancer research. It has particular expertise in hormonal therapy, chemotherapy, and quality of life studies for breast cancer patients. Key certifications and accreditations include ethical review by an internal Ethics Committee and oversight by an Independent Data Monitoring Committee.

Unique Features and Advantages:

ETOP IBCSG Partners Foundation is distinguished by its extensive international collaboration network, involving up to 500 participating sites worldwide. The foundation emphasizes personalized solutions and process transparency, ensuring high-quality communication and support for its clients. Its philosophy is rooted in a collaborative spirit, aiming to serve women with breast cancer through dedicated research and tailored treatment approaches.

Vendor Overview

Categories